Survival of NHD13+, NHD13+p53+/−, and NHD13+p53−/− mice with MDS or AML
| Mice . | NHD13+ . | NHD13+p53+/− . | NHD13+p53−/− . | p53+/− . | p53−/− . |
|---|---|---|---|---|---|
| Median survival, d | |||||
| MDS | 236 | 200 | 126 | ||
| AML | 324 | 246 | 130 | ||
| Overall | 307 | 205 | 127 | 382 | 178 |
| Total number (%) | |||||
| Died from MDS | 7 (30) | 14 (56) | 10 (56) | ||
| Died from AML | 16 (70) | 11 (44) | 8 (44) | ||
| Overall | 23 (100) | 25 (100) | 18 (100) | 24 | 23 |
| Mice . | NHD13+ . | NHD13+p53+/− . | NHD13+p53−/− . | p53+/− . | p53−/− . |
|---|---|---|---|---|---|
| Median survival, d | |||||
| MDS | 236 | 200 | 126 | ||
| AML | 324 | 246 | 130 | ||
| Overall | 307 | 205 | 127 | 382 | 178 |
| Total number (%) | |||||
| Died from MDS | 7 (30) | 14 (56) | 10 (56) | ||
| Died from AML | 16 (70) | 11 (44) | 8 (44) | ||
| Overall | 23 (100) | 25 (100) | 18 (100) | 24 | 23 |
MDS indicates myelodysplastic syndrome; and AML, acute myeloid leukemia.